From our new CFO profile CombiMatrix. It merged
Post# of 152462
(Total Views: 588)
Posted On: 05/06/2025 9:16:11 PM
From our new CFO profile CombiMatrix.
It merged away, buy it reminds of our FcRn:
CombiMatrix specializes in pre-implantation genetic diagnostics and screening, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies.
* Excerpt from a Sept. 2021 profile:
In his most recent operating role, Hoffman was Chief Financial Officer (CFO) of San Diego-based Heron Pharmaceuticals, a Nasdaq-listed, commercial-stage drug developer with a pipeline of acute pain therapeutics. During his tenure at Heron, the company raised more than $650 million and launched its second commercial drug product. Hoffman’s career in the biotechnology sector began in 1997 at Arena Pharmaceuticals, where he was a member of the founding management team and rose to become CFO, holding that position for ten years. While at Arena, he was involved in its Initial Public Offering (IPO) and financings, raising more than $1.5 billion. Hoffman was the financial lead in two Arena acquisitions, including a Swiss manufacturing facility, and he became managing director of the facility upon the closing of the transaction. Hoffman also was an advisor to the Financial Accounting Standard Board (FASB) for 10 years (2010 to 2020), advising the United States accounting rulemaking organizations on emerging issues and new financial guidance. As a founder of Day For Change, a not-for-profit that serves underprivileged and abused children in San Diego, Hoffman has served on its board of directors for 20 years.
_____
Having been an advisor to FASB, he knows all the accounting rules & how to maximize benefits if dealing with a foreign headquartered entity like say a ---- GSK, etc...
Accounting, FASB, Manufacturing, Avastin, $6.5b Pfizer deal, children foundation...on & on.
Our new CFO is extremely well rounded.
It merged away, buy it reminds of our FcRn:
CombiMatrix specializes in pre-implantation genetic diagnostics and screening, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies.
* Excerpt from a Sept. 2021 profile:
In his most recent operating role, Hoffman was Chief Financial Officer (CFO) of San Diego-based Heron Pharmaceuticals, a Nasdaq-listed, commercial-stage drug developer with a pipeline of acute pain therapeutics. During his tenure at Heron, the company raised more than $650 million and launched its second commercial drug product. Hoffman’s career in the biotechnology sector began in 1997 at Arena Pharmaceuticals, where he was a member of the founding management team and rose to become CFO, holding that position for ten years. While at Arena, he was involved in its Initial Public Offering (IPO) and financings, raising more than $1.5 billion. Hoffman was the financial lead in two Arena acquisitions, including a Swiss manufacturing facility, and he became managing director of the facility upon the closing of the transaction. Hoffman also was an advisor to the Financial Accounting Standard Board (FASB) for 10 years (2010 to 2020), advising the United States accounting rulemaking organizations on emerging issues and new financial guidance. As a founder of Day For Change, a not-for-profit that serves underprivileged and abused children in San Diego, Hoffman has served on its board of directors for 20 years.
_____
Having been an advisor to FASB, he knows all the accounting rules & how to maximize benefits if dealing with a foreign headquartered entity like say a ---- GSK, etc...
Accounting, FASB, Manufacturing, Avastin, $6.5b Pfizer deal, children foundation...on & on.
Our new CFO is extremely well rounded.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼